Michael McCully is the founder of Syndeio Biosciences. Syndeio Biosciences has raised $90M in total funding. Latest round: Series A.
Michael G. McCully is the Co-Founder, President, and Chief Operating Officer of Syndeio Biosciences, a clinical-stage biotechnology company focused on central nervous system diseases. He leads efforts to advance therapies for restoring and enhancing synaptic health.
Full founder directory · Investor directory · Company funding database · Fundraising library